These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 33430859)

  • 1. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary data of familial hypercholesterolemia (FH) patients in Romania.
    Dumitrescu A; Mosteoru S; Vinereanu D; Dan GA; Gaita L; Gaita D
    Atherosclerosis; 2018 Oct; 277():304-307. PubMed ID: 30270063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.
    Petrov I; Postadzhiyan A; Vasilev D; Kasabov R; Tokmakova M; Nikolov F; Istatkov V; Zhao B; Mutafchiev D; Petkova R
    Adv Ther; 2021 May; 38(5):2323-2338. PubMed ID: 33754300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
    Casula M; Olmastroni E; Pirillo A; Catapano AL; ; ; ; ; ;
    Atherosclerosis; 2018 Oct; 277():413-418. PubMed ID: 30270079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
    Yaman S; Ozdemir D; Akman BT; Cakir B; Ersoy O
    Postgrad Med; 2021 Mar; 133(2):146-153. PubMed ID: 32744105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Schmidt N; Schmidt B; Dressel A; Gergei I; Klotsche J; Pieper L; Scharnagl H; Kleber ME; März W; Lehnert H; Pittrow D; Stalla G; Wittchen HU; Grammer TB
    Atherosclerosis; 2017 Nov; 266():24-30. PubMed ID: 28946037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V; Kuznetsova T; Julius U
    Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A
    Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cross sectional study of familial hypercholesterolemia in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].
    Wang XN; Wang F; Ye P; Hu DY; Zhao SP; Wang YJ; Mu YM; Yan XW; Li ZQ; Wei YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jun; 49(6):564-571. PubMed ID: 34126723
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
    Barkas F; Rizos CV; Liamis G; Skoumas I; Garoufi A; Rallidis L; Kolovou G; Tziomalos K; Skalidis E; Sfikas G; Kotsis V; Doumas M; Anagnostis P; Lambadiari V; Anastasiou G; Koutagiar I; Attilakos A; Kiouri E; Kolovou V; Polychronopoulos G; Koutsogianni AD; Zacharis E; Koumaras C; Antza C; Boutari C; Liberopoulos E
    J Clin Lipidol; 2024; 18(3):e394-e402. PubMed ID: 38331687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.